Acetaminophen in the post-ischemia reperfused myocardium

Experimental Biology and Medicine

Volumn 227, Issue 11, 2002, Pages 1031-1038

  Golfetti, Roseli ^a,c   Vandyke, Knox ^b   Rork, Tyler ^d   Spiler, Norell ^d   Merrill, Gary ^a  

^a RUTGERS UNIVERSITY   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c UNIVERSITY OF CAMPINAS   (Brazil)

^d NONE

Author keywords

2,6,8 trihydroxypurine; Global myocardial ischemia; Mechanical function

Indexed keywords

CREATINE KINASE; PARACETAMOL; PEROXYNITRITE; URIC ACID;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; GUINEA PIG; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; ISCHEMIC HEART DISEASE; ISOLATED HEART; NONHUMAN;

ANIMALIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 0036917791     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020222701112     Document Type: Article

References (37)

1. Ameer B, Greenblatt J. Pharmacological review of paracetamol (acetaminophen). Ann Intern Med 87:202-209, 1977.
2. Fairbrothers JE. Paracetamol: A comprehensive description. In: Florey K, Ed. Analytical Profiles of Drug Substances. New York: Academic Press, pp 1-109, 1974.
3. Prescott LF. Paracetamol (Acetaminophen): A Critical Bibliographic Review, 2nd Ed. London: Taylor & Francis, 2001.
4. O'Neil MJ, Smith A, Heckleman PE, Eds. The Merck Index, 13th Ed. Whitehouse Station, NJ: Merck Research Laboratories, Merck & Co., Inc., p.10, 2001.
5. VanDyke K, Sacks M, Qazi N. A new screening method to detect water-soluble antioxidants: Acetaminophen and other phenols react as antioxidants and destroy peroxynitrite-based luminol-dependent chemiluminescence. J Biolumin Chemilumin 13:339-348, 1998.
6. VanDyke K, McConnell P, Marquardt L. Green tea extract and its polyphenols markedly inhibit luminol-dependent chemiluminescence activated by peroxynitrite or SIN-1. Luminescence 15:37-43, 2000.
7. Aviram M. Review of human studies on oxidative damage and anti-oxidant protection related to cardiovascular diseases. Free Rad Res 33(Suppl):S85-97, 2000.
8. Bergendi L, Benes L, Durackova Z, Ferencik M. Chemistry, physiology, and pathology of free radicals. Life Sci 65:1865-1874, 1999.
9. Catapano AL, Maggi FM, Tragni E. Low-density lipoprotein oxidation, antioxidants, and atherosclerosis. Curr Opin Cardiol 15:355-363, 2000.
10. Diplock AT. Introduction: Markers of oxidative damage and antioxidant modulation. Free Rad Res 33(Suppl):S21-26, 2000.
11. Salonen JT. Markers of oxidative damage and antioxidant protection: Assessment of LDL oxidation. Free Rad Res 33(Suppl):S41-S46, 2000.
12. National Family Opinion Organization Center for Cardiovascular Education Inc., New Providence. New Jersey 1996-2000; http://www.heartinfo.com/features/analgesics/index.htm.
13. Merrill G, McConnell P, VanDyke K, Powell S. Coronary and myocardial effects of acetaminophen: Protection during ischemia-reperfusion. Am J Physiol Heart Circ Physiol 280:H2631-H2638, 2001.
14. Merrill G, Goldberg E. Antioxidant properties of acetaminophen and cardioprotection. Bas Res Cardiol 96:423-430, 2001.
15. Merrill G. Acetaminophen and low-flow myocardial ischemia: Efficacy and antioxidant mechanisms. Am J Physiol Heart Circ Physiol 282:H1341-H1349, 2002.
16. Bunger R, Haddy FJ, Gerlach E. Coronary responses to dilating substances and competitive inhibition by theophylline in the isolated, perfused guinea pig heart. Pflugers Arch 358:212-224, 1975.
17. Bunger R, Haddy FJ, Querengasser A, Gerlach E. An isolated guinea pig heart preparation with in vivo-like features. Pflugers Arch 353:317-326, 1975.
18. Wei HM, Kang YH, Merrill GF. Adenosine's role in the coronary vasodilation of global myocardial hypoxia: Effects of adenosine deaminase. Am J Physiol Heart Circ Physiol 254:H1004-H1009, 1988.
19. Kang YH, Wei HM, Merrill GF. Role of adenosine in catecholamine-induced coronary functional hyperemia. J Cardiovas Pharmacol 15:940-946, 1990.
20. Wei HM, Friedrichs GS, Merrill GF. Route-dependent effects of 2-chloroadenosine and theophylline in isolated perfused guinea pig hearts. Cardiovas Res 25:529-536, 1991.
21. Stowe DF. Vasodilator responses to moderate hypoxia after submaximal adenosine injection or coronary occlusion in isolated perfused guinea pig hearts. Circ Res 47:392-399, 1980.
22. Ahrenholz DH, Schubert W, Solem LD. Creatine kinaase as a prognostic indicator in electrical injury. Surgery 104:741-747, 1988.
23. Mehta HB, Popovich BK, Dillmann WH. Ischemia induces changes in the level of mRNAs coding for stress protein 71 and creatine kinase M. Circ Res 63:512-517, 1988.
24. Preus M, Bhargava AS, Rahman Khater AE, Gunzel P. Diagnostic value of serum creatine kinase and lactate dehydrogenase isoenzyme determinations for monitoring early cardiac damage in rats. Toxicol Lett 42:225-233, 1988.
25. Nielsen L, Ludvigsen B. Improved method for determination of creatine kinase. J Lab Clin Med 62:159-168, 1963.
26. Rosalki SB. An improved procedure for serum creatine phosphokinase determination. J Lab Clin Med 69:696-704, 1967.
27. McHugh NA, Merrill GF, Powell SR. Estrogen diminishes postischemic production of hydroxyl radical. Am J Physiol Heart Circ Physiol 274:H1950-H1954, 1998.
28. Wu X, Lee CC, Muzny DA, Caskey CT. Urate oxidase: Primary structure and evolutionary implications. Proc Natl Acad Sci USA 86: 9412-9416, 1989.
29. Arnes BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: A hypothesis. Proc Natl Acad Sci USA 78:6858-6862, 1981.
30. Skinner KA, Whites CR, Patel R, Tan S, Barnes S, Kirk M, Darley-Usmar V, Parks DA. Nitrosation of uric acid by peroxynitrite. J Biol Chem 273:24491-24497, 1998.
31. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality: The NHANES I epidemiologic followup study, 1971-1992. JAMA 283:2404-2410, 2000.
32. Faulkner K, Fridovich I. Luminol and lucigenin as detectors of super-oxide. Free Rad Biol Med 15:447-451, 1993.
33. Sare M, Bozkurt S, Onuk M, Gurel M, Ercan S. The effects of indomethacin, NDGA, allopurinol and superoxide dismutase on prostaglandin E2 and leukotriene C4 levels after mesenteric ischemia-reperfusion injury. Prostaglandins Leukotrienes Essential Fatty Acids 55:379-383, 1996.
34. Voigtlander J, Leiderer R, Muhlbayer D, Habazettl H. Time-dependent efficacy of initial reperfusion with 2,3-butanedione monoxime (BDM) on release of cytosolic enzymes and ultrastructural damage in isolated hearts. Thoracic Cardiovascular Surgeon 47:244-250, 1999.
35. Figueredo VM, Diamond J, Zhou HZ, Camacho SA. Chronic dipyridamole therapy produces sustained protection against cardiac ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 277:H2091-H2097, 1999.
36. Chong PH, Kezele B, Pontikes PJ. Effect of acetaminophen on atherosclerosis. Ann Pharmacother 35:1476-1479, 2001.
37. Chou TM, Greenspan P. Effects of acetaminophen on the myeloper-oxidase-hydrogen peroxide-nitrite mediated oxidation of LDL. Biochim Biophys Acta 1981:57-63, 2002.